SUNESIS PHARMACEUTICALS INC 4
4 · SUNESIS PHARMACEUTICALS INC · Filed Jun 2, 2017
Insider Transaction Report
Form 4
Carchedi Steve
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-05-31+25,000→ 25,000 totalExercise: $2.96Exp: 2027-05-31→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests over one (1) year in equal monthly installments from the date of grant.